This allowed the authors to demonstrate that attenuation of TGF-β signaling in T cells renders mice resistant to tumor growth, using two different transplantable tumor models (EL4 thymoma and B16/F10 melanoma). The gene discussed is TGFB1; the disease is melanoma.